Robert Michael Savel II's Net Worth
$679 Thousand
Who is Robert Michael Savel II?
Robert Michael Savel II does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include OTONOMY, INC., and PDL BIOPHARMA, INC..
SEC CIK
Robert Michael Savel II's CIK is 0001394692
Past Insider Trading and Trends
2015 was Robert Michael Savel II's most active year for acquiring shares with 7 total transactions. Robert Michael Savel II's most active month to acquire stocks was the month of December. 2015 was Robert Michael Savel II's most active year for disposing of shares, totalling 12 transactions. Robert Michael Savel II's most active month to dispose stocks was the month of November. 2015 saw Robert Michael Savel II paying a total of $177,453.01 for 36,256 shares, this is the most they've acquired in one year. In 2015 Robert Michael Savel II cashed out on 70,000 shares for a total of $979,135.79, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
OTONOMY, INC. No price found
Chief Technical OfficerRobert Michael Savel II owns 145,735 units of Common Stock. From 2014 to 2022 Robert Michael Savel II acquired a total of 171,256 shares in OTONOMY, INC. at a cost of $177,453.01, Robert also disposed a total of 40,699 shares of OTONOMY, INC. equalling to $856,849.55.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.76% | -5.70K |
$2.40 | -$13,692.34 | 145.74K |
Mar 25 - Mar 28
| |||
Form 4
| +85.96% | 70K |
—
|
—
| 151.43K |
Jan 14
| |||
Form 4
| +395.52% | 65K |
—
|
—
| 81.43K |
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
$15.44 | -$105,582.88 | 1.26K |
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
$14.43 | -$95,499.09 | 1.26K |
Scheduled
|
Sep 14
| ||
Form 4
|
—
|
0
|
$14.10 | -$481,703.84 | 1.26K |
Scheduled
|
Jun 15
| ||
Form 4
|
∞
| 1.26K |
$13.60 | $17,081.60 | 1.26K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDL BIOPHARMA, INC. No price found
SVP Technical Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||